Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal Cancer

Study ID
NCT01718873

Study type
Interventional

Study phase
Phase 3

Study status
Completed

Trial Acronym

OBELICS

Trial Summary

The purpose of this study is to evaluate if giving bevacizumab prior to chemotherapy compared to giving bevacizumab at the same time as chemotherapy improves patient overall response to treatment.

More informations

Trial Starting Date

May 31,2012

Requirements

Gender All
Minimum age 18 Years
Maximum age 75 Years

Enrollement Limit

230